Yamamichi Gaku

ヤマミチガク | Yamamichi Gaku

Affiliation and department：
Research theme for competitive and other funds (2)：

2021 - 2024 大阪臨床研究ネットワーク基盤を利用した新規骨転移血液バイオマーカーの多施設研究
2020 - 2022 Elucidation of the mechanism of expression of GDPP, a novel blood biomarker of bone metastases

Papers (66)：

Gaku Yamamichi, Taigo Kato, Tadashi Watabe, Koji Hatano, Motohide Uemura, Norio Nonomura. Current Status of Prostate-specific Membrane Antigen-targeted Alpha Radioligand Therapy in Prostate Cancer. Anticancer research. 2024. 44. 3. 879-888
Toshihiro Uemura, Atsunari Kawashima, Kentaro Jingushi, Daisuke Motooka, Takuro Saito, Sassi Nesrine, Toshiki Oka, Yohei Okuda, Akinaru Yamamoto, Gaku Yamamichi, et al. Bacteria-derived DNA in serum extracellular vesicles are biomarkers for renal cell carcinoma. Heliyon. 2023. 9. 9
植村俊彦, 河嶋厚成, 神宮司健太郎, 元岡大祐, ネスリン・サッシ, 岡利樹, 奥田洋平, 山本顕生, 山道岳, 冨山栄輔, et al. 血中細胞外小胞内の細菌由来DNAは腎癌診断および免疫治療予後予測マーカーとなる. 腎癌研究会会報. 2023. 53. 51-51
Toshiki Oka, Koji Hatano, Yohei Okuda, Akinaru Yamamoto, Toshihiro Uemura, Gaku Yamamichi, Eisuke Tomiyama, Yu Ishizuya, Yoshiyuki Yamamoto, Taigo Kato, et al. The presence of lymph node metastases and time to castration resistance predict the therapeutic effect of enzalutamide for castration-resistant prostate cancer. International journal of clinical oncology. 2022. 28. 3. 427-435
山道岳, 加藤大悟, 明庭昇平, 岡利樹, 奥田洋平, 植村俊彦, 山本顕生, 冨山栄輔, 石津谷祐, 山本致之, et al. 前立腺癌におけるGDF15プロペプチドの骨転移診断マーカーとしての有用性. 日本分子腫瘍マーカー研究会誌. 2022. 38. 42-43

ｍore...

MISC (138)：

河嶋厚成, 山本顕生, NESRINE Sassi, 木村友則, 三田真史, 植村俊彦, 山道岳, 冨山栄輔, 石津谷祐, 山本致之, et al. Development of blood based diagnostic markers of urothelial carcinoma using chiral amino acids. 日本泌尿器科学会総会(Web). 2023. 110th
波多野浩士, 岡利樹, 二村圭祐, 石津谷祐, 奥田洋平, 植村俊彦, 山道岳, 冨山栄輔, 山本致之, 加藤大悟, et al. Systematic mapping of radiosensitivity and gene interactions identifies a novel therapeutic target in prostate cancer. 日本泌尿器科学会総会(Web). 2023. 110th
山本致之, 山本致之, 河嶋厚成, 河嶋厚成, 森島敏隆, 奥田洋平, 岡利樹, 植村俊彦, 山道岳, 冨山栄輔, et al. Effect of cycle number of platinum-based chemotherapy for metastatic urothelial cancer. 日本泌尿器科学会総会(Web). 2023. 110th
山道岳, 加藤大悟, 本山雄一, 王谷英達, 明庭昇平, 冨山栄輔, 石津谷祐, 山本致之, 波多野浩士, 河嶋厚成, et al. GDPP is a novel blood biomarker in bone metastasis of prostate cancer by fueling the vicious cycle. 日本泌尿器科学会総会(Web). 2023. 110th
石津谷祐, 岡利樹, 奥田洋平, 植村俊彦, 山本顕生, 山道岳, 冨山栄輔, 山本致之, 加藤大悟, 波多野浩士, et al. Diagnostic accuracy of percutaneous CT-guided core needle biopsy for metastatic lesions of urological malignancies. 日本泌尿器科学会総会(Web). 2023. 110th

ｍore...

Lectures and oral presentations (2)：

High performance of 5-aminolevulinic acid induced fluorescent urine cytology for detecting urothelial carcinoma
(American Urological Association Annual Meeting 2020 2020)
High diagnostic efficacy of 5-aminolevulinic acid induced fluorescence urine cytology for urothelial carcinoma
(European Association of Urology Annual Meeting 2019 2019)

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page